Skip to main content
. 2019 Oct 17;102(3):607–619. doi: 10.1093/biolre/ioz202

Table 1.

Pregnancy outcomes of ESC chimeric embryos carrying mtDNA mutations.

Cell line (sex) Pathogenic mutations (heteroplasmy %) Type of negative selection for mutations No. of ET No. of implantation (%/ET) No. of total term pups (%/ET) No. of live pups (%/ET) No. of chimeras No. of high chimerism chimerasb (sex)
ND6-100 (female) 6106A > T COXI (94%) 13026 T > C ND5 (95%) 13967C > T ND6 (100%) High heteroplasmy 533 195 (36.6%) 90 (16.9%) 76 (14.3%) 35 4 (female)
ND2-50 (female) 4871A > T ND2 (50%) High heteroplasmy 588 227 (38.6%) 74 (12.6%) 64 (10.9%) 34 2 (female) 1 (male)
ATP8-62 (male) 7769C > G ATP8 (62%) High heteroplasmy 394 139 (35.3%) 47 (11.9%) 39 (9.9%) 25 7 (male)
COXIII-81 (female) 6726A > G COXI (63%) 9138G > A/9278A > T COXIII (81%/81%) 12853C > T/13441C > T ND5 (52%/91%) Selected gene with high heteroplasmy 278 93 (33.5%) 23 (8.3%)a 19 (6.8%)a 12 1 (male)
Control-1 (female) None None 239 92 (38.4%) 40 (16.7%)a 35 (14.6%)a 17 3 (female) 1 (male)

aThe rate of term pups in COXIII-81 chimeras was significantly lower than that in control-1 chimeras (P < 0.01).

bHigh chimerism chimera was defined as ≥50% chimerisms determined by coat colors and whole mtDNA sequencing for C4891T SNP between B6N ESC (C) and host ICR (T).